Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development
about
Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsyWhole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor ProgressionMaternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancer.Clinical trials of antiangiogenic therapy for hepatocellular carcinoma.Patient-derived xenografts undergo mouse-specific tumor evolution.Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma.Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.Oncogenic dependency on β-catenin in liver cancer cell lines correlates with pathway activation.Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer.PDXliver: a database of liver cancer patient derived xenograft mouse models.Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models.Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking
P2860
Q33821373-81A276EB-3352-4783-899E-E404B2EDAA34Q35837444-D30FCB9B-767E-4939-8AE0-8DB7A6611908Q36905898-DB005200-A7CC-4D39-9515-BC5CB9218070Q38743040-20AE79EA-7B33-43F0-8612-ED7FE139443EQ46291099-E077CAE9-9E6E-42C9-B1C3-1274ED6DB101Q47141545-3BAE092E-3BE3-4C50-AF2A-01EBEE33A0B8Q48317424-D81467DE-C741-4461-BAB6-00075EB0448CQ49165832-406C9A4C-FCC3-47B5-9C80-5803639AA933Q50057702-6F20C92C-C4A8-4519-8E0E-CC80D9599139Q53685286-A88D79CB-FFC1-46CB-8F82-7F846C7F06DEQ54111915-DF187848-362A-4363-A7FB-190941C4DEEAQ58601322-4939131B-B13E-4CB2-B94A-10AE8D2EFFD4
P2860
Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Genomic characterization of a ...... ls for preclinical development
@ast
Genomic characterization of a ...... ls for preclinical development
@en
type
label
Genomic characterization of a ...... ls for preclinical development
@ast
Genomic characterization of a ...... ls for preclinical development
@en
prefLabel
Genomic characterization of a ...... ls for preclinical development
@ast
Genomic characterization of a ...... ls for preclinical development
@en
P2093
P2860
P356
P1433
P1476
Genomic characterization of a ...... ls for preclinical development
@en
P2093
Chi-Chung Chan
Douglas D Fang
Guibai Liang
Hongyang Wang
Hongye Sun
P2860
P304
20160-20176
P356
10.18632/ONCOTARGET.3969
P407
P577
2015-05-21T00:00:00Z